课题基金 / 基金详情

EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin

EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin
EMPOWER:评估通过基于网络的电子健康自我管理计划减少接受阿片类药物治疗的慢性疼痛患者吗啡当量剂量的能力:随机多站点临床
批准号:
10174898
负责人:
T John WINHUSEN
金额:
$41.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2023-06-30

项目摘要

项目成果

T John WINHUSEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary-Abstract: The treatment of chronic non-cancer pain has largely fallen to primary care physicians who often, due to healthcare system constraints, rely exclusively on long-term opioid therapy (LOT). Based on the adverse consequences and inadequate evidence of effectiveness for LOT, the CDC recently developed recommendations designed to decrease the use of LOT and the morphine equivalent dose (MED) for patients receiving LOT. However, the majority of people receiving LOT report that opioid medication is significantly beneficial and even critical to managing their pain. Compounding the problem is poor access to non- pharmacologic therapies for many patients, particularly in rural and lower socioeconomic communities, due to insurance reimbursement structures and limited availability of pain services. The importance of testing adjunctive therapies to reduce MED was noted in NIDA’s new strategic plan as was the importance of evaluating interventions that are scalable and, thus, more likely to be used. Chronic pain patients are increasingly using the internet for information and support; hence an affordable and effective web-based intervention could dramatically increase access to pain treatment. A web-based chronic pain program, the Chronic Pain Management Program (referred to as E-health), includes multiple learning centers that train skills such as cognitive restructuring, emotion regulation, goal setting, activity and exercise promotion, social support, relaxation techniques, and behavioral activation. The learning activities can be completed within a 4- month subscription period, the cost of which is $25/month. The results of two prior randomized controlled trials (RCTs) found E-health to be efficacious in decreasing pain and medication use. While these results are promising, they need to be replicated in a larger RCT and with patients being treated in primary care, where the majority of chronic pain patients are treated. Specific aims for the present project are to: 1) Conduct a RCT comparing E-health+ to treatment as usual (TAU). Four hundred patients being treated with ≥20 mg/day MED for chronic pain at primary care practices within one of two healthcare systems will be randomized in a 1:1 ratio to TAU or to TAU plus E-health (E-health+). TAU will consist of LOT from a primary care physician; MED and physician visits will be tracked through the electronic health record (EHR). TAU will be further characterized using the Assessment of Chronic Illness Care, which assesses the degree to which a practice uses six strategies that encourage high-quality care. Participants will complete assessments at baseline, the end of the 4-month E-health treatment period, and at 6 months post-treatment. 2) Test our conceptual model of E-health’s mechanisms of change, including hypothesized mediators (i.e., pain self-efficacy, coping strategies, knowledge about pain/opioid therapy, and stress) and moderators (neurocognitive function: executive function and verbal learning ability) of E-health’s impact on decreasing MED and pain intensity.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Opioid dose and pain effects of an online pain self-management program to augment usual care in adults with chronic pain: a multisite randomized clinical trial.
在线疼痛自我管理计划的阿片类药物剂量和疼痛影响,以增强成人慢性疼痛的常规护理:一项多中心随机临床试验。
DOI: 10.1097/j.pain.0000000000002785
发表时间: 2023-04-01
期刊: Pain
影响因子: 7.4
作者: []
通讯作者:
DOI: 10.1016/j.cct.2020.106245
发表时间: 2021-03
期刊: Contemporary clinical trials
影响因子: 2.2
作者: [Winhusen T, Wilson M, Dolor RJ, Theobald J, Lewis D, Regan SL, Vonder Meulen MB]
通讯作者: Vonder Meulen MB
The Ohio Valley Node of the Clinical Trials Network
  • 批准号:
    10652032
  • 项目类别:
  • 资助金额:
    $37.9万
  • 财政年份:
    2022
  • 负责人:
    T John WINHUSEN
  • 依托单位:
The Ohio Valley Node of the Clinical Trials Network
  • 批准号:
    10621497
  • 项目类别:
  • 资助金额:
    $50.25万
  • 财政年份:
    2022
  • 负责人:
    T John WINHUSEN
  • 依托单位:
The Ohio Valley Node of the Clinical Trials Network
  • 批准号:
    10441828
  • 项目类别:
  • 资助金额:
    $3.32万
  • 财政年份:
    2021
  • 负责人:
    T John WINHUSEN
  • 依托单位:
The Ohio Valley Node of the Clinical Trials Network
  • 批准号:
    10441986
  • 项目类别:
  • 资助金额:
    $90.04万
  • 财政年份:
    2021
  • 负责人:
    T John WINHUSEN
  • 依托单位:
海外基金